Skip to main content

Acer Therapeutics Inc.

ACERDelisted Nov 20, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001069308

Acer Therapeutics Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 20, 2023; 30 institutions reported holding it in 13F filings for Q3 2023, worth $3.40M in total; no superinvestor held it.

13F holders, Q2 2022

Institutional positions in Acer Therapeutics Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
28
+7 vs. Q1 2022
Shares held
1.56M
+135.9K (+9.6%) vs. Q1 2022
Total value
$1.96M
−$2.16M (−52.5%) vs. Q1 2022
New holders
7
9 more added
Sold out
0
5 more reduced

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACER on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 28 institutions
Q1 2021: 30 institutionsQ2 2021: 30 institutionsQ3 2021: 25 institutionsQ4 2021: 24 institutionsQ1 2022: 21 institutionsQ2 2022: 28 institutionsQ3 2022: 28 institutionsQ4 2022: 32 institutionsQ1 2023: 26 institutionsQ2 2023: 27 institutionsQ3 2023: 30 institutionsQ4 2023: 1 institutionQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2022: $1.96M
Q1 2021: $5.15MQ2 2021: $4.47MQ3 2021: $3.91MQ4 2021: $3.35MQ1 2022: $4.12MQ2 2022: $1.96MQ3 2022: $2.22MQ4 2022: $6.14MQ1 2023: $3.48MQ2 2023: $2.32MQ3 2023: $3.40MQ4 2023: $1.00KQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ACER and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20231$1.00K
Q3 202330$3.40M
Q2 202327$2.32M
Q1 202326$3.48M
Q4 202232$6.14M
Q3 202228$2.22M
Q2 202228$1.96M
Q1 202221$4.12M
Q4 202124$3.35M
Q3 202125$3.91M
Q2 202130$4.47M
Q1 202130$5.15M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Acer Therapeutics Inc.; share changes are against Q1 2022.

Institutions holding ACER in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Nantahala Capital Management, LLC741,010$934.0K0.08%−36,810−4.7%Reduced
Vanguard Group Inc280,419$353.0K0.00%+2,204+0.8%Added
BlackRock Inc.120,105$151.0K0.00%+17,065+16.6%Added
Goldman Sachs Group Inc93,381$118.0K0.00%−1,852−1.9%Reduced
Geode Capital Management, LLC90,815$114.0K0.00%+6,644+7.9%Added
Renaissance Technologies LLC69,700$88.0K0.00%+47,700+216.8%Added
State Street Corp23,465$30.0K0.00%−2,100−8.2%Reduced
Copperwynd Financial, LLC23,255$29.0K0.02%+23,255New
Citadel Advisors LLC22,574$28.0K0.00%+22,574New
Northern Trust Corp19,406$24.0K0.00%+268+1.4%Added
Hunter Associates Investment Management LLC19,000$24.0K0.01%+19,000New
Two Sigma Advisers, LP11,900$15.0K0.00%+11,900New
Bank of New York Mellon Corp11,075$14.0K0.00%−58−0.5%Reduced
Virtu Financial LLC10,742$14.0K0.00%+10,742New
Rockefeller Capital Management L.P.7,500$9.00K0.00%+7,500New
Tower Research Capital LLC (TRC)2,462$3.00K0.00%+1,664+208.5%Added
Morgan Stanley2,175$3.00K0.00%+2,167+27,087.5%Added
Simplex Trading, LLC2,691$3.00K0.00%+2,449+1,012.0%Added
Group One Trading, L.P.1,771$2.00K0.00%+1,771New
Larson Financial Group LLC922$1.00K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA179$2260.00%00.0%Unchanged
FMR LLC381$00.00%−209−35.4%Reduced
Advisor Group Holdings, Inc.200$00.00%00.0%Unchanged
Burleson & Company, LLC365$00.00%00.0%Unchanged
JPMorgan Chase & Co48$00.00%00.0%Unchanged
Wells Fargo & Company68$00.00%+10+17.2%Added
JFS Wealth Advisors, LLC24$00.00%00.0%Unchanged
UBS Group AG33$00.00%00.0%Unchanged